GEODE CAPITAL MANAGEMENT, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Back to VKTX Full portfolio

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$67,750,460

-$2,416,366 QoQ

Shares Held

2,082,067

+4.4% QoQ

Ownership

1.79%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. VKTX ranks #54 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

All Filings in VKTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$67,750,460	2,082,067	+4.4%	Shares	Defined	2026-05-15
2025-12-31	$70,166,826	1,994,509	+24.0%	Shares	Defined	2026-02-09
2025-09-30	$42,274,165	1,608,606	-16.4%	Shares	Defined	2025-11-12
2025-06-30	$50,967,582	1,923,305	-3.1%	Shares	Defined	2025-08-08
2025-03-31	$47,922,994	1,984,389	+5.5%	Shares	Defined	2025-05-13
2024-12-31	$75,679,891	1,880,713	+0.9%	Shares	Defined	2025-02-12
2024-09-30	$117,988,757	1,863,667	+0.2%	Shares	Defined	2024-11-12
2024-06-30	$98,549,936	1,859,082	-20.1%	Shares	Defined	2024-08-09
2024-03-31	$190,795,878	2,326,779	+9.3%	Shares	Defined	2024-05-13
2023-12-31	$39,608,463	2,128,343	+5.0%	Shares	Defined	2024-02-13
2023-09-30	$22,436,543	2,026,788	+9.8%	Shares	Defined	2023-11-13
2023-06-30	$29,930,776	1,846,439	+113.9%	Shares	Defined	2023-08-11
2023-03-31	$14,372,812	863,232	+31.9%	Shares	Defined	2023-05-15
2022-12-31	$6,150,476	654,306	+0.2%	Shares	Defined	2023-02-13
2022-09-30	$1,776,260	653,037	-4.8%	Shares	Defined	2022-11-14
2022-06-30	$1,981,814	685,749	-46.9%	Shares	Defined	2022-08-12
2022-03-31	$3,876,801	1,292,267	+9.4%	Shares	Defined	2022-05-13
2021-12-31	$5,435,613	1,181,655	-0.5%	Shares	Defined	2022-02-11
2021-09-30	$7,456,382	1,187,322	+2.3%	Shares	Defined	2021-11-12
2021-06-30	$6,950,346	1,160,325	+9.0%	Shares	Defined	2021-08-13
2021-03-31	$6,733,746	1,064,624	+9.3%	Shares	Defined	2021-05-12
2020-12-31	$5,481,863	973,688	+2.6%	Shares	Defined	2021-02-12
2020-09-30	$5,522,004	948,798	-3.3%	Shares	Defined	2020-11-13
2020-06-30	$7,073,219	981,029	+1.5%	Shares	Defined	2020-08-13
2020-03-31	$4,525,157	966,914	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.